Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk Factors for Skin Toxicities Associated with Bendamustine-Based Chemotherapy in Patients with Non-Hodgkin Lymphoma.
Uchida M, Mori Y, Akiba K, Miyasaka M, Hirano T, Ikesue H, Yamaguchi Y, Takano A, Maegawa N, Shimomura Y, Hosohata K, Muroi N, Ishikawa T, Hashida T, Nakamura T. Uchida M, et al. Among authors: ishikawa t. Biol Pharm Bull. 2020 Oct 1;43(10):1577-1582. doi: 10.1248/bpb.b20-00428. Epub 2020 Aug 14. Biol Pharm Bull. 2020. PMID: 32801282 Free article.
Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma.
Maruyama D, Nagai H, Fukuhara N, Kitano T, Ishikawa T, Shibayama H, Choi I, Hatake K, Uchida T, Nishikori M, Kinoshita T, Matsuno Y, Nishikawa T, Takahara S, Tobinai K. Maruyama D, et al. Among authors: ishikawa t. Cancer Sci. 2016 Dec;107(12):1785-1790. doi: 10.1111/cas.13076. Epub 2016 Nov 25. Cancer Sci. 2016. PMID: 27616553 Free PMC article. Clinical Trial.
Small Cell Carcinoma Mimicking Acute Leukemia.
Shimomura Y, Imai Y, Ishikawa T. Shimomura Y, et al. Among authors: ishikawa t. Intern Med. 2017 Sep 1;56(17):2375-2376. doi: 10.2169/internalmedicine.8585-16. Epub 2017 Aug 10. Intern Med. 2017. PMID: 28794375 Free PMC article. No abstract available.
Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era.
Katoh D, Ochi Y, Yabushita T, Ono Y, Hiramoto N, Yoshioka S, Yonetani N, Matsushita A, Hashimoto H, Kaji S, Imai Y, Ishikawa T. Katoh D, et al. Among authors: ishikawa t. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e91-e97. doi: 10.1016/j.clml.2017.08.096. Epub 2017 Aug 14. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28918104
7,648 results